Anti-CCP-positive patients with RA have a higher 10-year probability of fracture evaluated by FRAX ®: a registry study of RA with osteoporosis/fracture

Positive anticyclic citrullinated peptide (anti-CCP+) is associated with bone loss in patients with rheumatoid arthritis (RA). However, whether overall positivity or specific levels of anti-CCP are associated ...

Source: Arthritis Research and Therapy - January 30, 2018 Category: Rheumatology Authors: Tien-Tsai Cheng, Shan-Fu Yu, Fu-Mei Su, Yin-Chou Chen, Ben Yu-Jih Su, Wen-Chan Chiu, Chung-Yuan Hsu, Jia-Feng Chen, Chi-Hua Ko and Han-Ming Lai Tags: Research article Source Type: research